Vimarsana
Biggest News Aggregation in the World

Page 12 - Nasdaq Bbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bbio Today - Breaking & Trending Today

Insider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) CEO Sells 120,000 Shares of Stock - Vimarsana News

Insider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) CEO Sells 120,000 Shares of Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CEO Neil Kumar sold 120,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 5th. The shares were sold at an average price of $15.46, for a total value of $1,855,200.00. Following the completion of the transaction, the chief executive officer now directly owns […]

Source: wkrb13.com
BridgeBio Pharma, Inc. (NASDAQ:BBIO) CFO Sells $857,475.00 in Stock - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) CFO Sells $857,475.00 in Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 55,500 shares of the company’s stock in a transaction that occurred on Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total transaction of $857,475.00. Following the completion of the transaction, the chief financial officer now owns […]

Source: wkrb13.com
BridgeBio Announces Positive Phase 2 Cohort 5 Results of - Vimarsana News

BridgeBio Announces Positive Phase 2 Cohort 5 Results of

- In the highest dose level (Cohort 5, 0.25 mg/kg once daily), the mean change from baseline in annualized height velocity (AHV) at six months was +3.03...

Renaissance Technologies LLC Raises Stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO) - Vimarsana News

Renaissance Technologies LLC Raises Stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Renaissance Technologies LLC raised its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) by 230.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 1,366,746 shares of the company’s stock after acquiring an additional 953,500 shares during the period. Renaissance Technologies LLC owned approximately 0.91% of BridgeBio […]

BridgeBio Pharma to Host Educational Roundtable with - Vimarsana News

BridgeBio Pharma to Host Educational Roundtable with

PALO ALTO, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...